EUVIMEDEUVIMED entdecken
Crossref

Abstract 6741: Patterns in Chronic Kidney Disease (CKD) Screening Among Patients with Hypertension (HTN)

Yun Han, Satabdi Chatterjee, Christina Shay, Lindsay GS Bengtson, Anh Thy Nguyen, Bonnie MK Donato, Shelby Corman

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.6741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Yun Han und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The American College of Cardiology (ACC)/American Heart Association (AHA) strongly recommend annual CKD screening, including estimated glomerular filtration (eGFR) and urine albumin-creatinine ratio (uACR), in patients with HTN (Class 1 recommendation). However, limited evidence exists regarding screening patterns among this at-risk population. Research Questions: This study aimed to describe adherence to CKD screening guidance in patients with HTN, and to quantify missed opportunities for CKD screening at primary care physician (PCP) and specialist (cardiologist, nephrologist, or endocrinologist) visits in this population.

Methods

This was a retrospective cohort study conducted using electronic health records-linked claims from Optum® Market Clarity. The study included patients with a new or existing diagnosis of HTN between May 1, 2021-September 30, 2023 (index date), who were ≥18 years old, had no diagnosis or lab evidence of CKD during the 12-month pre-index period, and ≥15 months of post-index follow-up. The primary outcome was the proportion of patients who were screened for CKD, defined as ≥1 eGFR and/or uACR test, in Year 1 (months 0-15, allowing a 3-month grace period) and Year 2 (months 16-30, among those with ≥30 months of follow-up) post-index date, overall and in subgroups with comorbid type 2 diabetes (T2D) and/or cardiovascular disease (CVD). Secondary outcomes included the proportion of patients with eGFR screening in Years 1 and 2, uACR in Years 1 and 2; and the number of visits to PCPs and specialists during the follow-up period, among those who did not undergo any CKD screening in Year 1.

Results

A total of 2,352,979 patients (54% female; median age 64 years) were included in Year 1 and 1,168,872 in Year 2. In Year 1, 55.0%, 11.7%, and 11.5% of patients had ≥1 eGFR, ≥1 uACR, and both tests, respectively. Overall, screening rates appeared to increase slightly from Year 1 to 2. eGFR screening was similar by subgroup, while uACR screening in Year 1 varied by comorbidity status, ranging from 35.5% among patients with HTN only (n=11,488) to 4.3% among those with HTN and CVD (n=369,784; Table). In year 1, patients with HTN who were not screened (n=1,052,219) had a mean of 3.4 primary care visits, and 31% had at least one specialist visit.

Conclusions

In patients with HTN, CKD screening was suboptimal, with less than 15% with HTN receiving annual uACR screening. Unscreened patients had multiple missed opportunities for screening given their PCP and specialist visits. In light of the AHA/ACC guidelines strongly recommending annual uACR tests in HTN, and recognition of albuminuria as an early marker of CV risk, there is a need to improve uACR screening for early CKD detection and management.

Zitieren

APA

Han, Y., Chatterjee, S., Shay, C., Bengtson, L. G., Nguyen, A. T., Donato, B. M., & Corman, S. (2026). Abstract 6741: Patterns in Chronic Kidney Disease (CKD) Screening Among Patients with Hypertension (HTN). Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.6741

Vancouver

Han Y, Chatterjee S, Shay C, Bengtson LG, Nguyen AT, Donato BM, et al. Abstract 6741: Patterns in Chronic Kidney Disease (CKD) Screening Among Patients with Hypertension (HTN). Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.6741

BibTeX
@article{Han2026,
  author = {Han, Yun and Chatterjee, Satabdi and Shay, Christina and Bengtson, Lindsay GS and Nguyen, Anh Thy and Donato, Bonnie MK and Corman, Shelby},
  title = {Abstract 6741: Patterns in Chronic Kidney Disease (CKD) Screening Among Patients with Hypertension (HTN)},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.6741}
}
Kostenlos starten →